West Pharmaceutical Services, Inc.

NYSE:WST Stock Report

Mkt Cap: US$20.0b

West Pharmaceutical Services Past Performance

How has West Pharmaceutical Services performed over the past 5 years?

Past Performance Score

3/6

Past Performance Score 3/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


34.1%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: WST has high quality earnings.

Growing Profit Margin: WST's current net profit margins (21.7%) are lower than last year (22.8%).


Past Earnings Growth Analysis

Earnings Trend: WST's earnings have grown significantly by 34.1% per year over the past 5 years.

Accelerating Growth: WST's earnings growth over the past year (3%) is below its 5-year average (34.1% per year).

Earnings vs Industry: WST earnings growth over the past year (3%) underperformed the Life Sciences industry 13.6%.


Return on Equity

High ROE: WST's Return on Equity (25.5%) is considered high.


Return on Assets


Return on Capital Employed


Discover strong past performing companies